PURPOSE: High mobility group (HMG) transcription factors of the T-cell-specific transcription factor/lymphoid enhancer binding factor (TCF/LEF) family are a class of intrinsic regulators that are dynamically expressed in the embryonic mouse retina. Activation of TCF/LEFs is a hallmark of the Wnt/beta-catenin pathway; however, the requirement for Wnt/beta-catenin and noncanonical Wnt signaling during mammalian retinal development remains unclear. The goal of the study was to characterize more fully a TCF/LEF-responsive retinal progenitor population in the mouse embryo and to correlate this with Wnt/beta-catenin signaling. METHODS: TCF/LEF activation was analyzed in the TOPgal (TCF optimal promoter) reporter mouse at embryonic ages and compared to Axin2 mRNA expression, an endogenous readout of Wnt/beta-catenin signaling. Reporter expression was also examined in embryos with a retina-specific deletion of the beta-catenin gene (Ctnnb1), using Six3-Cre transgenic mice. Finally, the extent to which TOPgal cells coexpress cell cycle proteins, basic helix-loop-helix (bHLH) transcription factors, and other retinal cell markers was tested by double immunohistochemistry. RESULTS: TOPgal reporter activation occurred transiently in a subpopulation of embryonic retinal progenitor cells. Axin2 was not expressed in the central retina, and TOPgal reporter expression persisted in the absence of beta-catenin. Although a proportion of TOPgal-labeled cells were proliferative, most coexpressed the cyclin-dependent kinase inhibitor p27/Kip1. CONCLUSIONS: TOPgal cells give rise to the four earliest cell types: ganglion, amacrine, horizontal, and photoreceptor. TCF/LEF activation in the central retina does not correlate with Wnt/beta-catenin signaling, pointing to an alternate role for this transcription factor family during retinal development.
PURPOSE: High mobility group (HMG) transcription factors of the T-cell-specific transcription factor/lymphoid enhancer binding factor (TCF/LEF) family are a class of intrinsic regulators that are dynamically expressed in the embryonic mouse retina. Activation of TCF/LEFs is a hallmark of the Wnt/beta-catenin pathway; however, the requirement for Wnt/beta-catenin and noncanonical Wnt signaling during mammalian retinal development remains unclear. The goal of the study was to characterize more fully a TCF/LEF-responsive retinal progenitor population in the mouse embryo and to correlate this with Wnt/beta-catenin signaling. METHODS:TCF/LEF activation was analyzed in the TOPgal (TCF optimal promoter) reporter mouse at embryonic ages and compared to Axin2 mRNA expression, an endogenous readout of Wnt/beta-catenin signaling. Reporter expression was also examined in embryos with a retina-specific deletion of the beta-catenin gene (Ctnnb1), using Six3-Cre transgenic mice. Finally, the extent to which TOPgal cells coexpress cell cycle proteins, basic helix-loop-helix (bHLH) transcription factors, and other retinal cell markers was tested by double immunohistochemistry. RESULTS: TOPgal reporter activation occurred transiently in a subpopulation of embryonic retinal progenitor cells. Axin2 was not expressed in the central retina, and TOPgal reporter expression persisted in the absence of beta-catenin. Although a proportion of TOPgal-labeled cells were proliferative, most coexpressed the cyclin-dependent kinase inhibitor p27/Kip1. CONCLUSIONS: TOPgal cells give rise to the four earliest cell types: ganglion, amacrine, horizontal, and photoreceptor. TCF/LEF activation in the central retina does not correlate with Wnt/beta-catenin signaling, pointing to an alternate role for this transcription factor family during retinal development.
Authors: Melanie R Roberts; Anita Hendrickson; Christopher R McGuire; Thomas A Reh Journal: Invest Ophthalmol Vis Sci Date: 2005-08 Impact factor: 4.799
Authors: S Verbeek; D Izon; F Hofhuis; E Robanus-Maandag; H te Riele; M van de Wetering; M Oosterwegel; A Wilson; H R MacDonald; H Clevers Journal: Nature Date: 1995-03-02 Impact factor: 49.962
Authors: V Brault; R Moore; S Kutsch; M Ishibashi; D H Rowitch; A P McMahon; L Sommer; O Boussadia; R Kemler Journal: Development Date: 2001-04 Impact factor: 6.868
Authors: Eric E Beier; Tzong-Jen Sheu; Deborah Dang; Jonathan D Holz; Resika Ubayawardena; Philip Babij; J Edward Puzas Journal: J Biol Chem Date: 2015-05-14 Impact factor: 5.157
Authors: Elizabeth J Bankhead; Mary P Colasanto; Kayla M Dyorich; Milan Jamrich; L Charles Murtaugh; Sabine Fuhrmann Journal: Am J Pathol Date: 2014-11-03 Impact factor: 4.307
Authors: Peter D Westenskow; Jon B McKean; Fumi Kubo; Shinichi Nakagawa; Sabine Fuhrmann Journal: Invest Ophthalmol Vis Sci Date: 2010-05-12 Impact factor: 4.799
Authors: Jeffrey M Harder; Qian Ding; Kimberly A Fernandes; Jonathan D Cherry; Lin Gan; Richard T Libby Journal: Mol Cell Neurosci Date: 2012-07-24 Impact factor: 4.314
Authors: Kyeong Hwan Moon; Hyoung-Tai Kim; Dahye Lee; Mahesh B Rao; Edward M Levine; Dae-Sik Lim; Jin Woo Kim Journal: Dev Cell Date: 2017-12-14 Impact factor: 12.270